Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Ascendis Hit With CRL Over Variability in Delivered Dose in Drug/Device Combo May 1, 2023 FDA Unveils Risk-Based Enforcement Approach to Homeopathic Drugs December 19, 2017 FDA AdComms Give Thumbs-Up to Rexulti for Dementia Agitation April 14, 2023